Eugia US is recalling one lot of injectable vancomycin nationwide after a glass particle was found inside a vial. The notice posted by the FDA asks hospitals, pharmacies and other facilities to stop using the affected lot and quarantine their stock. Eugia said it had received no reports of adverse events related to the recall at the time of the notice.
Which vials are affected
The recall covers lot 3VM26026A of vancomycin hydrochloride for injection, 1.25 grams in a 30-milliliter single-dose vial. The expiration on the label is July 2028. The carton’s National Drug Code is 55150-471-10 and the vial’s is 55150-471-01. The lot number identifies the recalled stock within that presentation.
Eugia says glass particles in an injection can block blood vessels or cause clotting. The company warns that newborns, infants and people with impaired organ function may be particularly susceptible. The antibiotic is used for several serious bacterial infections, including bloodstream and heart valve infections.
What patients and facilities can do
If you received vancomycin and have a problem you think may be related, the recall notice advises contacting your health care provider. If you have a question about which lot you received, ask the facility that administered it. Patients and clinicians can report suspected adverse reactions or product quality problems through FDA MedWatch.
Facilities that sent the lot elsewhere should notify recipients. For return instructions, the notice lists Qualanex at 1-800-505-9291 or [email protected]. Its phone line is staffed weekdays from 7 a.m. to 4 p.m. Central.
